• Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens–Johnson syndrome, and erythema multiforme. Arch Dermatol 129:9296. The diagnostic criteria are reflected in the currently used following Japanese guidance; Diagnostic criteria of Stevens–Johnson syndrome (Hashimoto K representing a Research Group on the Conquest of Intractable Diseases, Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, 2005) and Diagnostic criteria of Toxic Epidermal Necrolysis (Hashimoto K representing a Research Group on the Conquest of Intractable Diseases, Health and Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, 2005).
  • Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT. (2004) Medical genetics: a marker for Stevens–Johnson syndrome. Nature 428:486.
  • Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M, Kashiwagi M, Muramatsu M. (2010) HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Eplepsia 51:297300.
  • Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Sawada J, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R; JSAR research group. (2008) HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9:16171622.
  • Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V. (2008) Carbamazepine and phenytoin induced Stevens–Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49:20872091.
  • Lonjou C, Thomas L, Borot N, Ledger N, De Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC; RegiSCAR Group. (2006) A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99107.
  • Man CB, Kwan P, Baum L, Yu E, Lau KM, Cheng AS, Ng MH. (2007) Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48:10151018.
  • Mehta TY, Prajapati LM, Mittal B, Joshi CG, Sheth JJ, Patel DB, Dave DM, Goyal RK. (2009) Association of HLA-B*1502 allele and carbamazepine-induced Stevens–Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 75:579582.
  • Middleton D, Menchaca L, Rood H, Komerofsky R. (2003) Brief communication. New allele frequency database: Tissue Antigens 61:403407.
  • Tanaka H, Akaza T, Juji T. (1996) Report of the Japanese central bone marrow data center. Clin Transpl 1996:139144.
  • Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Chen P, Lin SY, Chen WH, Konyoung P, Khunarkornsiri U, Auvichayapat N, Pavakul K, Kulkantrakorn K, Choonhakarn C, Phonhiamhan S, Piyatrakul N, Aungaree T, Pongpakdee S, Yodnopaglaw P. (2010) Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population. Epilepsia 51:926930.
  • Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S. (2008) HLA class I and II gene polymorphisms in Stevens–Johnson syndrome with ocular complications in Japanese. Mol Vis 14:550555.
  • Weltzien HU, Moulton C, Martin S, Padovan E, Hartmann U, Kohler J. (1996) T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology 107:141151.
  • Wu Y, Farrell J, Pirmohamed M, Park BK, Naisbitt DJ. (2007) Generation and characterization of antigen-specific CD4 + , CD8 + , and CD4 + CD8 +  T-cell clones from patients with carbamazepine hypersensitivity. J Allergy Clin Immunol 119:973981.
  • Yang CW, Hung SI, Juo CG, Lin YP, Fang WH, Lu IH, Chen ST, Chen YT. (2007) HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens–Johnson syndrome. J Allergy Clin Immunol 120:870877.
  • Yang G, Deng YJ, Qin H, Zhu BF, Chen F, Shen CM, Sun ZM, Chen LP, Wu J, Mu HF, Lucas R. (2010) HLA-B*15 subtypes distribution in Han population in Beijing, China, as compared with those of other populations. Int J Immunogenet 37:205212.